These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35732988)

  • 1. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
    Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
    Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
    Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
    Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
    Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
    Front Immunol; 2022; 13():821423. PubMed ID: 35145523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
    Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
    J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
    Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
    Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.
    Hassanein M; Hight MR; Buck JR; Tantawy MN; Nickels ML; Hoeksema MD; Harris BK; Boyd K; Massion PP; Manning HC
    Mol Imaging Biol; 2016 Feb; 18(1):18-23. PubMed ID: 25971659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.
    Cooper AJ; Krasnikov BF; Pinto JT; Kung HF; Li J; Ploessl K
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):108-20. PubMed ID: 22613816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic Assessment of
    Grkovski M; Goel R; Krebs S; Staton KD; Harding JJ; Mellinghoff IK; Humm JL; Dunphy MPS
    J Nucl Med; 2020 Mar; 61(3):357-366. PubMed ID: 31601700
    [No Abstract]   [Full Text] [Related]  

  • 9. PET Imaging of
    Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
    Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
    Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of (2S,4S)-4-[
    Huang Y; Liu Y; Li C; Li Z; Chen H; Zhang L; Liang Y; Wu Z
    Mol Pharm; 2023 Oct; 20(10):5195-5205. PubMed ID: 37647563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Seo Y; Craig MC; Murphy ST; Feng J; Chen X; Yuneva M
    Mol Imaging; 2022; 2022():5185951. PubMed ID: 35967756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (2S, 4R)-4-[
    Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
    Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS Mutation Detection with (2
    Liu S; Liu F; Hou X; Zhang Q; Ren Y; Zhu H; Yang Z; Xu X
    Mol Pharm; 2024 Apr; 21(4):2034-2042. PubMed ID: 38456403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic PET/CT imaging of
    Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Xie Q; Zhu L; Li N; Kung HF; Yang Z
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2280-2292. PubMed ID: 32166510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging.
    Abu Aboud O; Habib SL; Trott J; Stewart B; Liang S; Chaudhari AJ; Sutcliffe J; Weiss RH
    Cancer Res; 2017 Dec; 77(23):6746-6758. PubMed ID: 29021138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of: (2
    Miner MWG; Liljenbäck H; Virta J; Helin S; Eskola O; Elo P; Teuho J; Seppälä K; Oikonen V; Yang G; Kindler-Röhrborn A; Minn H; Li XG; Roivainen A
    Front Oncol; 2021; 11():730358. PubMed ID: 34692505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alanine and glycine conjugates of (2S,4R)-4-[
    Zha Z; Ploessl K; Lieberman BP; Wang L; Kung HF
    Nucl Med Biol; 2018 May; 60():19-28. PubMed ID: 29525446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Valtorta S; Toscani D; Chiu M; Sartori A; Coliva A; Brevi A; Taurino G; Grioni M; Ruffini L; Vacondio F; Zanardi F; Bellone M; Moresco RM; Bussolati O; Giuliani N
    Front Oncol; 2021; 11():760732. PubMed ID: 34712616
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.